Source: DGNews | Posted 8 years ago
FDA Approves New Avandamet (Rosiglitazone Maleate/Metformin) Dosage Strengths For Treatment Of Type 2 Diabetes
Tags:
New Dosage Strengths Offer Physicians and Patients Dosing Flexibility For Managing Type 2 Diabetes
PHILADELPHIA, PA -- August 27, 2003 -- GlaxoSmithKline (NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) approved new dosage strengths for Avandamet
Comments